Analyst Jason Cassorla works at CITI and is focused on the Healthcare sector with 131 price targets and ratings documented since 2017 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 41.25% with an average time for price targets to be met of 99 days.
Most recent stock forecast was given on HCA, HCA Healthcare, Inc at 30-Jan-2023.
Jason Cassorla best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP - CLASS A).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP - CLASS A) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
20
$1.05 (5.54%)
22
2 months 20 days ago
1/6 (16.67%)
$4.39 (22.79%)
48
Buy
21
$2.05 (10.82%)
25
2 months 21 days ago
1/4 (25%)
$6.04 (34.74%)
7
Buy
20
$1.05 (5.54%)
24
2 months 21 days ago
0/3 (0%)
$8.03 (45.24%)
Buy
23
$4.05 (21.37%)
25
2 months 24 days ago
2/5 (40%)
$5.94 (35.51%)
15
Buy
20
$5.13 (34.50%)
23
3 months 24 days ago
0/4 (0%)
$5.27 (30.06%)
